Clinical Trial Update: A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating vatiquinone for Friedreich Ataxia has completed and posted results. The update confirms results availability as of 2026-04-08.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Vatiquinone

Snippet

Sponsor: PTC Therapeutics | Conditions: Friedreich Ataxia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-04-08